Ngm Biopharmaceuticals Inc
NGM
Revenue
165.00k
▼-417.00k▼-71.65%
3 Months ChangeAssets
168.87M
▼-23.28M▼-12.12%
3 Months ChangeLiabilities
20.23M
▼-2.12M▼-9.47%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-04-05
Form 8-K
ID: 0001193125-24-088076
2024-03-11
Form 8-K
ID: 0001628280-24-010229
2024-02-26
Form 8-K
ID: 0001193125-24-046296
2024-01-22
Form 8-K
ID: 0001193125-24-011619
2024-01-02
Form 8-K
ID: 0001193125-24-000219
2023-12-04
Form 8-K
ID: 0001193125-23-288513
2023-11-02
Form 10-Q
ID: 0001628280-23-036401
2023-11-02
Form 8-K
ID: 0001628280-23-036389
2023-10-17
Form 8-K
ID: 0001193125-23-257803
2023-08-11
Form 8-K
ID: 0001628280-23-029072